Aurélien Lorthioir

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi, Kintur Sanghvi, Manish Saxena et al. · The Lancet · 2021 · 416 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12

Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial

Michel Azizi, Héléna Pereira, Idir Hamdidouche et al. · Circulation · 2016 · 154 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Cécile Couchoud, Florian Bayer, Carole Ayav et al. · Kidney International · 2020 · 150 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +6

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial

Michel Azizi, Roland E. Schmieder, Felix Mahfoud et al. · Circulation · 2019 · 121 citations

Medicine, Cardiology, Surgery +16

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

Ajay J. Kirtane, Andrew Sharp, Felix Mahfoud et al. · JAMA Cardiology · 2023 · 82 citations · Full text

Medicine, Cardiology, Nephrology +15